A Post-Marketing Safety Study of Mounjaro® (Tirzepatide) in Chinese Participants who are Overweight or have Obesity with or without Type 2 Diabetes Mellitus in a Real-World SettingFirst published 28/01/2025 Last updated 28/01/2025 EU PAS number: EUPAS1000000461StudyPlanned